x
Breaking News
0

Celgene Corporation (CELG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Celgene's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
139.19 +2.48    +1.81%
18:25:17 GMT - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US1510201049 
CUSIP: 151020104
  • Volume: 2,584,223
  • Bid/Ask: 139.18 / 139.20
  • Day's Range: 137.23 - 139.53
Start Trading with Nadex
Celgene 139.19 +2.48 +1.81%

CELG Overview

 
Information about the Celgene Corporation Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close136.71
Day's Range137.23 - 139.53
Revenue12.19B
Open137.83
52 wk Range96.93 - 147.17
EPS3.22
Volume2,584,223
Market Cap106.96B
Dividend (Yield)0 (N/A)
Average Vol. (3m)3,937,170
P/E Ratio42.51
Beta1.88
1-Year Change38.79%
Shares Outstanding782,350,672
Next Earnings DateOct 26, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Sell Strong Buy
Summary Strong Buy Strong Buy Strong Buy Neutral Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Bearish 5H Current
Three Inside Up 1D Current
Completed Patterns
Three Outside Down 1W 1 Oct 08, 2017
Engulfing Bearish 1W 2 Oct 01, 2017
Falling Three Methods 1D 3 Oct 12, 2017

Celgene Corporation News & Analysis

Celgene Corporation Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 139.19 139.18 139.20 2,584,223 +1.81% USD 18:25:17  
  Mexico 2,639.00 0.00 0.00 1,330 +1.50% MXN 17:23:00  
  Switzerland 142.00 0.00 0.00 0 0.00% USD 13/09  
  Switzerland 133.60 0.00 0.00 0 0.00% CHF 13/10  
  Xetra 118.40 118.00 118.85 861 +1.33% EUR 15:35:00  
  Berlin 115.96 118.03 118.53 0 +0.47% EUR 06:08:00  
  Frankfurt 116.93 118.10 118.35 278 +0.25% EUR 13:26:00  
  Stuttgart 118.07 117.93 118.43 0 +2.93% EUR 16:28:00  
  TradeGate 118.11 117.93 118.43 2,158 +1.69% EUR 17:46:00  
  Munich 117.10 0.00 0.00 21 +1.51% EUR 10:10:00  
  Vienna 116.800 0.000 0.000 0 0.00% EUR 16/10  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 160.20 160.87 159.23 +0.32 +0.20% 14.26M 18:25:17  
  Netflix 199.20 204.38 197.77 -3.48 -1.72% 20.57M 18:25:00  
  Tesla 354.21 356.22 350.07 +3.61 +1.03% 2.46M 18:24:47  
  Neothetics Inc 1.74 1.78 0.83 +1.22 +235.40% 46.35M 18:25:17  
  Facebook 175.26 175.96 174.36 +0.74 +0.43% 11.36M 18:25:10  
  NVIDIA 196.83 198.90 196.35 -1.10 -0.55% 9.31M 18:25:13  
  Amazon.com 1,005.35 1,011.47 1,004.39 -0.99 -0.10% 1.61M 18:25:14  
  Goldman Sachs 235.94 244.70 235.56 -6.47 -2.67% 5.34M 18:25:18  
  J&J 140.95 141.12 137.06 +4.83 +3.55% 7.10M 18:25:18  
  Transenterix Inc 4.1450 5.0000 3.2800 +1.3350 +47.51% 123.09M 18:25:14  

Celgene Corporation Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

7132

Equity Type

ORD

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) Start Trading
National Futures Association (United States), National Securities Depository (India), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading

My Sentiments

What is your sentiment on Celgene?
or
Vote to see community's results!

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Celgene Corporation
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest CELG Comments

George Kh
George Kh Aug 27, 2017 12:39PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi i am planning to invest in the Celgene. Is it good time to buy or need to wait it until reach the minimum?
Reply
0 0
Luke Martin
Luke Martin Oct 09, 2017 5:20AM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now is good
Reply
0 0
Luke Martin
Luke Martin Oct 10, 2017 4:56PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is your moment, we're in a 5% pullback against fundamental guidance, at 138 or 139 CELG stands out as a strong buy, at 161 CELG stands strong for long term growth
Reply
0 0
George Kh
George Kh 15 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Luke Martinokay thanks
Reply
0 0
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
 
 
 
Add Chart to Comment
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email